Northland Capmk Estimates DocGo’s Q3 Earnings (NASDAQ:DCGO)

DocGo Inc. (NASDAQ:DCGO) – Research analysts at Northland Capmk lifted their Q3 2025 earnings per share (EPS) estimates for DocGo in a report issued on Friday, February 28th. Northland Capmk analyst M. Latimore now anticipates that the company will post earnings per share of $0.04 for the quarter, up from their previous forecast of $0.03. The consensus estimate for DocGo’s current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo’s FY2025 earnings at $0.13 EPS.

Other research analysts have also issued reports about the company. Needham & Company LLC decreased their target price on DocGo from $7.00 to $4.00 and set a “buy” rating for the company in a report on Friday. Stifel Nicolaus decreased their target price on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and decreased their target price for the company from $5.00 to $2.85 in a report on Friday. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $4.89.

DocGo Trading Down 3.2 %

NASDAQ:DCGO opened at $2.99 on Monday. The firm has a market cap of $305.13 million, a PE ratio of 10.68, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00. The stock has a fifty day moving average price of $4.58 and a 200 day moving average price of $4.03. DocGo has a 12-month low of $2.75 and a 12-month high of $5.68.

Hedge Funds Weigh In On DocGo

Several institutional investors have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its position in DocGo by 1.3% in the 4th quarter. Invesco Ltd. now owns 177,953 shares of the company’s stock valued at $755,000 after acquiring an additional 2,312 shares during the period. Summit Investment Advisors Inc. increased its position in DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after acquiring an additional 2,968 shares during the period. SG Americas Securities LLC increased its position in DocGo by 12.9% in the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after acquiring an additional 4,905 shares during the period. Rhumbline Advisers increased its position in DocGo by 4.5% in the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock valued at $605,000 after acquiring an additional 6,204 shares during the period. Finally, Victory Capital Management Inc. increased its position in DocGo by 12.3% in the 4th quarter. Victory Capital Management Inc. now owns 57,649 shares of the company’s stock valued at $244,000 after acquiring an additional 6,300 shares during the period. Institutional investors and hedge funds own 56.44% of the company’s stock.

Insider Buying and Selling at DocGo

In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now owns 175,645 shares in the company, valued at approximately $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.70% of the stock is owned by insiders.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.